Analyze Diet
Biosensors & bioelectronics2004; 20(12); 2566-2580; doi: 10.1016/j.bios.2004.09.028

Rapid analysis of fatty acid-binding proteins with immunosensors and immunotests for early monitoring of tissue injury.

Abstract: Fatty acid-binding protein (FABP) holds promise for early detection of tissue injury. This small protein (15kD) appears earlier in the blood than large proteins after cell damage. Combined its characteristics of high concentration tissue contents and low normal plasma values provide the possibility of a rapid rise above the respective reference values, and thus an early indication of the appearance of tissue injury. A general review was presented on the current status of different types of FABP for the detection of tissue injury in patients with myocardial injury, brain injury and also in athletes or horses with skeletal muscle injury. To take full advantage of the characteristics of the early marker FABP, rapid analysis is a crucial parameter. In this review, an overview of the development of immunoassay for the quantification of FABP in buffer, plasma or whole blood was outlined. The characteristics of different FABP immunosensors and immunotests were described. The feasibility of these immunoassays to be used in routine clinical practice and in emergency case was also discussed. Nowadays, the improved automated immunoassays (e.g. a microparticle-enhanced turbidimetric immunoassay), less time-consuming bedside immunosensors and immunotests (e.g. a one-step FABP lateral flow immunotest), are the main advance technology in point-of-care testing. With these point-of-care tests, the application of FABP as an early tissue injury marker has a great potential for many clinical purposes.
Publication Date: 2004-11-18 PubMed ID: 15854826DOI: 10.1016/j.bios.2004.09.028Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research review focuses on the role and detection methods of fatty acid-binding proteins (FABPs) in indicating early tissue injury. The promising advances in immunosensors and immunotests, including less time-consuming and automated methods, are highlighted as key techniques in rapid and efficient detection of FABP levels for clinical use.

Significance of Fatty Acid-Binding Protein (FABP) in Detecting Tissue Injury

  • The small size of FABP allows it to appear in the blood quicker than larger proteins following tissue injury, making it a potential early indicator of cell damage.
  • Under normal conditions, FABP has low plasma values, but high tissue concentration. Therefore, a significant increase in plasma FABP indicates tissue damage.
  • The review covers the use of various types of FABP detection in patients with myocardial (heart) injury, brain injury, and in athletes or horses with skeletal muscle injury.

Advances in FABP Detection Methods

  • Rapid analysis of FABP is crucial to take full advantage of its use as an early marker of tissue injury.
  • Several methods for the quantification of FABP in buffer, plasma or whole blood have been developed over the years.
  • These methods have evolved to include immunosensors and immunotests that are specifically designed to detect FABP.
  • The attributes of various FABP immunosensors and immunotests have been assessed for their feasibility in routine clinical practice and emergency cases.

The Future of FABP in Point-of-Care Testing

  • Automated and less time-consuming immunoassays, such as a microparticle-enhanced turbidimetric immunoassay, present a substantial advancement in point-of-care testing.
  • One-step FABP lateral flow immunotests are identified as effective bedside immunosensors that can increase efficiency in the clinical setting.
  • With these advancements in point-of-care tests, the use of FABP as an early tissue injury marker has significant potential for various clinical applications.

Cite This Article

APA
Chan CP, Wan TS, Watkins KL, Pelsers MM, Van der Voort D, Tang FP, Lam KH, Mill J, Yuan Y, Lehmann M, Hempel A, Sanderson JE, Glatz JF, Renneberg R. (2004). Rapid analysis of fatty acid-binding proteins with immunosensors and immunotests for early monitoring of tissue injury. Biosens Bioelectron, 20(12), 2566-2580. https://doi.org/10.1016/j.bios.2004.09.028

Publication

ISSN: 0956-5663
NlmUniqueID: 9001289
Country: England
Language: English
Volume: 20
Issue: 12
Pages: 2566-2580

Researcher Affiliations

Chan, Cangel P Y
  • Department of Chemistry, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong SAR, PR China.
Wan, Terence S M
    Watkins, Keith L
      Pelsers, Maurice M A L
        Van der Voort, Daniëlle
          Tang, Francis P W
            Lam, Kenneth H K
              Mill, Jürgen
                Yuan, Yvonne
                  Lehmann, Matthias
                    Hempel, Albrecht
                      Sanderson, John E
                        Glatz, Jan F C
                          Renneberg, Reinhard

                            MeSH Terms

                            • Animals
                            • Biomarkers / blood
                            • Biosensing Techniques / instrumentation
                            • Biosensing Techniques / methods
                            • Blood Chemical Analysis / instrumentation
                            • Blood Chemical Analysis / methods
                            • Carrier Proteins / blood
                            • Connective Tissue Diseases / blood
                            • Connective Tissue Diseases / diagnosis
                            • Equipment Design
                            • Fatty Acid-Binding Proteins
                            • Humans
                            • Immunoassay / instrumentation
                            • Immunoassay / methods
                            • Monitoring, Physiologic / instrumentation
                            • Monitoring, Physiologic / methods
                            • Myocardial Infarction / blood
                            • Myocardial Infarction / diagnosis

                            Citations

                            This article has been cited 8 times.
                            1. Hendriks S, Stokmans SC, Plas M, Buurman WA, Spoorenberg SLW, Wynia K, Heineman E, van Leeuwen BL, de Haan JJ. Compromised intestinal integrity in older adults during daily activities: a pilot study. BMC Geriatr 2021 Nov 4;21(1):628.
                              doi: 10.1186/s12877-021-02573-4pubmed: 34736396google scholar: lookup
                            2. Voth M, Lustenberger T, Relja B, Marzi I. Is I-FABP not only a marker for the detection abdominal injury but also of hemorrhagic shock in severely injured trauma patients?. World J Emerg Surg 2019;14:49.
                              doi: 10.1186/s13017-019-0267-9pubmed: 31832083google scholar: lookup
                            3. Singh A, Pramanik A, Acharya P, Makharia GK. Non-Invasive Biomarkers for Celiac Disease. J Clin Med 2019 Jun 21;8(6).
                              doi: 10.3390/jcm8060885pubmed: 31234270google scholar: lookup
                            4. Voth M, Duchene M, Auner B, Lustenberger T, Relja B, Marzi I. I-FABP is a Novel Marker for the Detection of Intestinal Injury in Severely Injured Trauma Patients. World J Surg 2017 Dec;41(12):3120-3127.
                              doi: 10.1007/s00268-017-4124-2pubmed: 28721572google scholar: lookup
                            5. Gerede DM, Güleç S, Kiliçkap M, Kaya CT, Vurgun VK, Özcan ÖU, Göksülük H, Erol Ç. Comparison of a qualitative measurement of heart-type fatty acid-binding protein with other cardiac markers as an early diagnostic marker in the diagnosis of non-ST-segment elevation myocardial infarction. Cardiovasc J Afr 2015 Nov-Dec;26(6):204-9.
                              doi: 10.5830/CVJA-2015-028pubmed: 26212703google scholar: lookup
                            6. Conroy DJ, Millner PA, Stewart DI, Pollmann K. Biosensing for the environment and defence: aqueous uranyl detection using bacterial surface layer proteins. Sensors (Basel) 2010;10(5):4739-55.
                              doi: 10.3390/s100504739pubmed: 22399904google scholar: lookup
                            7. Makhsous M, Lin F, Pandya A, Pandya MS, Chadwick CC. Elevation in the serum and urine concentration of injury-related molecules after the formation of deep tissue injury in a rat spinal cord injury pressure ulcer model. PM R 2010 Nov;2(11):1063-5.
                              doi: 10.1016/j.pmrj.2010.08.002pubmed: 21093844google scholar: lookup
                            8. Liyan C, Jie Z, Xiaozhou H. Prognostic value of combination of heart-type fatty acid-binding protein and ischemia-modified albumin in patients with acute coronary syndromes and normal troponin T values. J Clin Lab Anal 2009;23(1):14-8.
                              doi: 10.1002/jcla.20276pubmed: 19140206google scholar: lookup